Literature DB >> 11050008

Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitized erythrocytes: a role for CD36 in malarial clearance.

I D McGilvray1, L Serghides, A Kapus, O D Rotstein, K C Kain.   

Abstract

Plasmodium falciparum is the most lethal form of malaria and is increasing both in incidence and in its resistance to antimalarial agents. An improved understanding of the mechanisms of malarial clearance may facilitate the development of new therapeutic interventions. We postulated that the scavenger receptor CD36, an important factor in cytoadherence of P falciparum-parasitized erythrocytes (PEs), might also play a role in monocyte- and macrophage-mediated malarial clearance. Exposure of nonopsonized PEs to Fc receptor-blocked monocytes resulted in significant PE phagocytosis, accompanied by intense clustering of CD36 around the PEs. Phagocytosis was blocked 60% to 70% by monocyte pretreatment with monoclonal anti-CD36 antibodies but not by antibodies to alpha(v)beta(3), thrombospondin, intercellular adhesion molecule-1, or platelet/endothelial cell adhesion molecule-1. Antibody-induced CD36 cross-linking did result in the early increase of surface CD11b expression, but there was no increase in, or priming for, tumor necrosis factor (TNF)-alpha secretion following either CD36 cross-linking or PE phagocytosis. CD36 clustering does support intracellular signaling: Antibody-induced cross-linking initiated intracellular tyrosine phosphorylation as well as extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein kinase (MAPK) phosphorylation. Both broad-spectrum tyrosine kinase inhibition (genistein) and selective ERK and p38 MAPK inhibition (PD98059 and SB203580, respectively) reduced PE uptake to almost the same extent as CD36 blockade. Thus, CD36-dependent binding and signaling appears to be crucial for the nonopsonic clearance of PEs and does not appear to contribute to the increase in TNF-alpha that is prognostic of poor outcome in clinical malaria.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11050008

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  108 in total

Review 1.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism.

Authors:  M Febbraio; D P Hajjar; R L Silverstein
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

2.  The terminal six amino-acids of the carboxy cytoplasmic tail of CD36 contain a functional domain implicated in the binding and capture of oxidized low-density lipoprotein.

Authors:  Eric Malaud; Delphine Hourton; Louise Marie Giroux; Ewa Ninio; Robin Buckland; John L McGregor
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

3.  Commentary on Myers et al.: growing role of the innate immunity receptor CD36 in central nervous system diseases.

Authors:  Lidia Garcia-Bonilla; Laibaik Park; Costantino Iadecola
Journal:  Exp Neurol       Date:  2014-08-23       Impact factor: 5.330

4.  Nonopsonic phagocytosis of erythrocytes infected with ring-stage Plasmodium falciparum.

Authors:  Kodjo Ayi; Samir N Patel; Lena Serghides; Todd G Smith; Kevin C Kain
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

5.  The scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion.

Authors:  Laura Helming; Julia Winter; Siamon Gordon
Journal:  J Cell Sci       Date:  2009-01-20       Impact factor: 5.285

6.  Uptake of oxidized low density lipoprotein by CD36 occurs by an actin-dependent pathway distinct from macropinocytosis.

Authors:  Richard F Collins; Nicolas Touret; Hirotaka Kuwata; Narendra N Tandon; Sergio Grinstein; William S Trimble
Journal:  J Biol Chem       Date:  2009-09-09       Impact factor: 5.157

7.  CD36-mediated hematoma absorption following intracerebral hemorrhage: negative regulation by TLR4 signaling.

Authors:  Huang Fang; Jing Chen; Sen Lin; PengFei Wang; YanChun Wang; XiaoYi Xiong; QingWu Yang
Journal:  J Immunol       Date:  2014-05-07       Impact factor: 5.422

8.  A distinct peripheral blood monocyte phenotype is associated with parasite inhibitory activity in acute uncomplicated Plasmodium falciparum malaria.

Authors:  Pattamawan Chimma; Christian Roussilhon; Panudda Sratongno; Ronnatrai Ruangveerayuth; Kovit Pattanapanyasat; Jean-Louis Pérignon; David J Roberts; Pierre Druilhe
Journal:  PLoS Pathog       Date:  2009-10-23       Impact factor: 6.823

9.  Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypes.

Authors:  Andrew E Fry; Anita Ghansa; Kerrin S Small; Alejandro Palma; Sarah Auburn; Mahamadou Diakite; Angela Green; Susana Campino; Yik Y Teo; Taane G Clark; Anna E Jeffreys; Jonathan Wilson; Muminatou Jallow; Fatou Sisay-Joof; Margaret Pinder; Michael J Griffiths; Norbert Peshu; Thomas N Williams; Charles R Newton; Kevin Marsh; Malcolm E Molyneux; Terrie E Taylor; Kwadwo A Koram; Abraham R Oduro; William O Rogers; Kirk A Rockett; Pardis C Sabeti; Dominic P Kwiatkowski
Journal:  Hum Mol Genet       Date:  2009-04-29       Impact factor: 6.150

10.  Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.

Authors:  Anja Scholzen; Diana Mittag; Stephen J Rogerson; Brian M Cooke; Magdalena Plebanski
Journal:  PLoS Pathog       Date:  2009-08-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.